Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause

References

• Rizzoli R. Postmenopausal osteoporosis: assessment and management. Best Pract Res Clin Endocrinol Metab. 2018;32(5):739–757.
   PubMed Web of Science ®Google Scholar
• Noh JY, Yang Y, Jung H. Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci. 2020;21(20):7623.
   PubMed Web of Science ®Google Scholar
• Li L, Wang Z. Ovarian aging and osteoporosis. Adv Exp Med Biol. 2018;1086:199–215.
   PubMed Web of Science ®Google Scholar
• Jochems C, Islander U, Erlandsson M, et al. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Arthritis Res Ther. 2005;7(4):R837–43.
   PubMed Web of Science ®Google Scholar
• Sanchez-Rodriguez MA, Ruiz-Ramos M, Correa-Munoz E, et al. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord. 2007;8(1):124.
   PubMedGoogle Scholar
• Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31(3):266–300.
   PubMed Web of Science ®Google Scholar
• Almeida M, Porter RM. Sirtuins and FoxOs in osteoporosis and osteoarthritis. Bone. 2019;121:284–292.
   PubMed Web of Science ®Google Scholar
• Kane AE, Sinclair DA. Sirtuins and NAD + in the development and treatment of metabolic and Cardiovascular Diseases. Circ Res. 2018;123(7):868–885.
   PubMed Web of Science ®Google Scholar
• Herranz D, Munoz-Martin M, Canamero M, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun. 2010;1:3.
   PubMed Web of Science ®Google Scholar
• Novelle MG, Wahl D, Dieguez C, et al. Resveratrol supplementation: Where are we now and where should we go? Ageing Res Rev. 2015;21:1–15.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Uehara S, Udagawa N, et al. Regulation of bone metabolism by WNT signals. J Biochem. 2016;159(4):387–392.
   PubMed Web of Science ®Google Scholar
• Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab. 2012;23(11):582–590.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1.
   PubMed Web of Science ®Google Scholar
• Peacock M, Turner CH, Econs MJ, et al. Genetics of osteoporosis. Endocr Rev. 2002;23(3):303–326.
   PubMed Web of Science ®Google Scholar
• Al-Barghouthi BM, Farber CR. Dissecting the genetics of osteoporosis using systems approaches. Trends Genet. 2019;35(1):55–67.
   PubMed Web of Science ®Google Scholar
• Clark SJ, Falchi M, Olsson B, et al. Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity. Obesity. 2012;20(1):178–185.
   PubMed Web of Science ®Google Scholar
• Hou Y, Su B, Chen P, et al. Association of SIRT1 gene polymorphism and its expression for the risk of alcoholic fatty liver disease in the Han population. Hepatol Int. 2018;12(1):56–66.
   PubMed Web of Science ®Google Scholar
• Aftanas LI, Anisimenko MS, Berdyugina DA, et al. SIRT1 allele frequencies in depressed patients of European descent in Russia. Front Genet. 2018;9:686.
   PubMed Web of Science ®Google Scholar
• Sarumaru M, Watanabe M, Inoue N, et al. Association between functional SIRT1 polymorphisms and the clinical characteristics of patients with autoimmune thyroid disease. Autoimmunity. 2016;49(5):329–337.
   PubMed Web of Science ®Google Scholar
• Yang G, Hamadeh IS, Katz J, et al. SIRT1/HERC4 locus associated with bisphosphonate-induced osteonecrosis of the jaw: an exome-wide association analysis. J Bone Miner Res. 2018;33(1):91–98.
   PubMed Web of Science ®Google Scholar
• Karlamangla AS, Burnett-Bowie SM, Crandall CJ. Bone health during the menopause transition and beyond. Obstet Gynecol Clin North Am. 2018;45(4):695–708.
   PubMed Web of Science ®Google Scholar
• Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the study of women’s health across the nation (SWAN). J Bone Miner Res. 2012;27(1):111–118.
   PubMed Web of Science ®Google Scholar
• Liu X-M, Chan HC, Ding G-L, et al. FSH regulates fat accumulation and redistribution in aging through the Gαi/Ca(2+)/CREB pathway. Aging Cell. 2015;14(3):409–420.
   PubMed Web of Science ®Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–1168.
   PubMed Web of Science ®Google Scholar
• Feng YL, Jiang XT, Ma FF, et al. Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity. Int J Mol Med. 2018;41(1):202–212.
   PubMed Web of Science ®Google Scholar
• Wong RH, Thaung Zaw JJ, Xian CJ, et al. Regular supplementation with resveratrol improves bone mineral density in postmenopausal women: a randomized, Placebo-controlled trial. J Bone Miner Res. 2020;35(11):2121–2131.
   PubMed Web of Science ®Google Scholar
• Okamoto M, Udagawa N, Uehara S, et al. Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis. Sci Rep. 2014;4:4493.
   PubMed Web of Science ®Google Scholar
• Moverare-Skrtic S, Henning P, Liu X, et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat Med. 2014;20(11):1279–1288.
   PubMed Web of Science ®Google Scholar
• Zainabadi K. Drugs targeting SIRT1, a new generation of therapeutics for osteoporosis and other bone related disorders? Pharmacol Res. 2019;143:97–105.
   PubMed Web of Science ®Google Scholar
• Iyer S, Han L, Bartell SM, et al. Sirtuin1 (Sirt1) promotes cortical bone formation by preventing β-catenin sequestration by FoxO transcription factors in osteoblast progenitors. J Biol Chem. 2014;289(35):24069–24078.
   PubMed Web of Science ®Google Scholar
• Ornstrup MJ, Harsløf T, Kjaer TN, et al. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. J Clin Endocrinol Metab. 2014;99(12):4720–4729.
   PubMed Web of Science ®Google Scholar
• Group WS. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1–129.
   PubMed Web of Science ®Google Scholar
• Fassio A, Idolazzi L, Rossini M, et al. The obesity paradox and osteoporosis. Eat Weight Disord. 2018;23(3):293–302.
   PubMed Web of Science ®Google Scholar
• Morris JA, Kemp JP, Youlten SE, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet. 2019;51(2):258–266.
   PubMed Web of Science ®Google Scholar
• Totomoch-Serra A, Munoz ML, Burgueno J, et al. Association of common polymorphisms in the VEGFA and SIRT1 genes with type 2 diabetes-related traits in Mexicans. Arch Med Sci. 2018;14(6):1361–1373.
   PubMed Web of Science ®Google Scholar